Giugliano RP, Pedersen TR, Saver JL, Sever PS, et al. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis. Stroke 2020;51:1546-1554.
PMID: 32312223